Comprehensive computational study in the identification of novel potential cholesterol lowering agents targeting proprotein convertase subtilisin/kexin type 9

References

• Abdel-Meguid, S. S., Abou-Gharbia, M., Blass, B., Childers, W., Elshourbagy, N., Ghidu, V., Martinez, R., Meyers, H., & Mousa, S. A. (2014). Anti-PCSK9 Compounds and Methods for the Treatment and/or Prevention of Cardiovascular Diseases 2014 Sept 25.
   Google Scholar
• Abdel-Meguid, S. S., Abou-Gharbia, M., Blass, B., Childers, W., Elshourbagy, N., Ghidu, V., Martinez, R., Meyers, H., & Mousa, S. A. (2015). Anti-PCSK9 Compounds and Methods for the Treatment and/or Prevention of Cardiovascular Diseases Patent US 2015/0376139.
   Google Scholar
• Abdel-Meguid, S. S., Elshourbagy, N. A., Meyers, H. V., & Mousa, S. A. (2017). Anti-Proprotein Convertase Subtilisin Kexin Type 9 (anti-PCSK9) Compounds and Methods of using the same in the Treatment and/or Prevention of Cardiovascular Diseases patent WO 2017/222953.
   Google Scholar
• Abdel-Meguid, S. S., Elshourbagy, N., Meyers, H., & Mousa, S. A. (2014). Anti-Proprotein Convertase Subtilisin Kexin Type 9 (anti-PCSK9) Compounds and Methods of using the same in the Treatment and/or Prevention of Cardiovascular Diseases patent WO 2014/150326.
   Google Scholar
• Abdi, H., & Williams, L. J. (2010). Principal component analysis. Wiley Interdisciplinary Reviews: Computational Statistics, 2(4), 433–459. https://doi.org/10.1002/wics.101
   Google Scholar
• Adasme, M. F., Linnemann, K. L., Bolz, S. N., Kaiser, F., Salentin, S., Haupt, V. J., & Schroeder, M. (2021). PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Research, 49(W1), W530–W534. https://doi.org/10.1093/nar/gkab294
   PubMed Web of Science ®Google Scholar
• Ahamad, S., Mathew, S., Khan, W. A., & Mohanan, K. (2022). Development of small-molecule PCSK9 inhibitors for the treatment of hypercholesterolemia. Drug Discovery Today, 27(5), 1332–1349. https://doi.org/10.1016/j.drudis.2022.01.014
   PubMed Web of Science ®Google Scholar
• Ames, B. N., Durston, W. E., Yamasaki, E., & Lee, F. D. (1973). Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proceedings of the National Academy of Sciences of the United States of America, 70(8), 2281–2285. https://doi.org/10.1073/pnas.70.8.2281
   PubMed Web of Science ®Google Scholar
• Ames, B. N., Lee, F. D., & Durston, W. E. (1973). An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proceedings of the National Academy of Sciences of the United States of America, 70(3), 782–786. https://doi.org/10.1073/pnas.70.3.782
   PubMed Web of Science ®Google Scholar
• Barta, T. E., Bourne, J. W., Monroe, K. D., Muehlemann, M. M., Pandey, A., & Bowers, S. (2017). Preparation of Phenylpiperazines as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Modulators and their use patent WO 2017/034997.
   Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Bickel, P., Diggle, P., Fienberg, S., Gather, U., Olkin, I., & Zeger, S. (2009). Springer series in statistics. Springer.
   Google Scholar
• Burley, S. K., Berman, H. M., Kleywegt, G. J., Markley, J. L., Nakamura, H., & Velankar, S. (2017). Protein Data Bank (PDB): The single global macromolecular structure archive. Methods in Molecular Biology (Clifton, N.J.), 1607, 627–641. https://doi.org/10.1007/978-1-4939-7000-1_26
   PubMedGoogle Scholar
• Burley, S. K., Bhikadiya, C., Bi, C., Bittrich, S., Chen, L., Crichlow, G. V., Christie, C. H., Dalenberg, K., Di Costanzo, L., Duarte, J. M., Dutta, S., Feng, Z., Ganesan, S., Goodsell, D. S., Ghosh, S., Green, R. K., Guranović, V., Guzenko, D., Hudson, B. P., … Zhuravleva, M. (2021). RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Research, 49(D1), D437–D451. https://doi.org/10.1093/nar/gkaa1038
   PubMed Web of Science ®Google Scholar
• Cavasotto, N. C., & Orry, A. J. W. (2007). Ligand docking and structure-based virtual screening in drug discovery. Current Topics in Medicinal Chemistry, 7(10), 1006–1014. https://doi.org/10.2174/156802607780906753
   PubMed Web of Science ®Google Scholar
• Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., Evans, S., Law, M., MacMahon, S., Martin, S., Neal, B., Poulter, N., Preiss, D., Ridker, P., Roberts, I., … Peto, R. (2016). Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet (London, England), 388(10059), 2532–2561. https://doi.org/10.1016/S0140-6736(16)31357-5
   PubMed Web of Science ®Google Scholar
• Evison, B. J., Palmer, J. T., Lambert, G., Treutlein, H., Zeng, J., Nativel, B., Chemello, K., Zhu, Q., Wang, J., Teng, Y., Tang, W., Xu, Y., Rathi, A. K., Kumar, S., Suchowerska, A. K., Parmar, J., Dixon, I., Kelly, G. E., & Bonnar, J. (2020). A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove. Bioorganic & Medicinal Chemistry, 28(6), 115344. https://doi.org/10.1016/j.bmc.2020.115344
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Guarnieri, F., Kulp, J. L., Jr., Kulp, J. L., 3rd, & Cloudsdale, I. S. (2019). Fragment-based design of small molecule PCSK9 inhibitors using simulated annealing of chemical potential simulations. PloS One, 14(12), e0225780. https://doi.org/10.1371/journal.pone.0225780
   PubMed Web of Science ®Google Scholar
• Guay, D., Crane, S., Lachance, N., Chiasson, J.-F., Truong, V. L., Lacombe, P., Skorey, K., & Seidah, N. G. (2014). Small Molecule Modulators of PCSK9 and Methods of use thereof patent WO 2014/139008.
   Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. https://doi.org/10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• Hotelling, H. (1933). Analysis of a complex of statistical variables into principal components. Journal of Educational Psychology, 24(6), 417–441. https://doi.org/10.1037/h0071325
   Google Scholar
• Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews. Drug Discovery, 3(11), 935–949. https://doi.org/10.1038/nrd1549
   PubMed Web of Science ®Google Scholar
• Londregan, A. T., Aspnes, G., Limberakis, C., Loria, P. M., McClure, K. F., Petersen, D. N., Raymer, B., Ruggeri, R. B., Wei, L., Xiao, J., & Piotrowski, D. W. (2018). Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9. Bioorganic & Medicinal Chemistry Letters, 28(23–24), 3685–3688. https://doi.org/10.1016/j.bmcl.2018.10.029
   PubMed Web of Science ®Google Scholar
• Londregan, A. T., Wei, L., Xiao, J., Lintner, N. G., Petersen, D., Dullea, R. G., McClure, K. F., Bolt, M. W., Warmus, J. S., Coffey, S. B., Limberakis, C., Genovino, J., Thuma, B. A., Hesp, K. D., Aspnes, G. E., Reidich, B., Salatto, C. T., Chabot, J. R., Cate, J. H. D., Liras, S., & Piotrowski, D. W. (2018). Small molecule proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: Hit to lead optimization of systemic agents. Journal of Medicinal Chemistry, 61(13), 5704–5718. https://doi.org/10.1021/acs.jmedchem.8b00650
   PubMed Web of Science ®Google Scholar
• Lv, Z., & Yang, B. (2022). Inventors; Preparation of Macrocyclic Compounds as Small Molecule PCSK9 Protein Inhibitor patent CN114085223.
   Google Scholar
• Maia, E. H. B., Assis, L. C., de Oliveira, T. A., da Silva, A. M., & Taranto, A. G. (2020). Structure-based virtual screening: From classical to artificial intelligence. Frontiers in Chemistry, 8, 343. https://doi.org/10.3389/fchem.2020.00343
   PubMed Web of Science ®Google Scholar
• Maliwal, D., Pissurlenkar, R. R. S., & Telvekar, V. (2022). Identification of novel potential anti-diabetic candidates targeting human pancreatic α-amylase and human α-glycosidase: An exhaustive structure-based screening. Canadian Journal of Chemistry, 100(5), 338–352. https://doi.org/10.1139/cjc-2021-0238
   Web of Science ®Google Scholar
• Mammen, A. L. (2016). Statin-associated autoimmune myopathy. The New England Journal of Medicine, 374(7), 664–669. https://doi.org/10.1056/NEJMra1515161
   PubMed Web of Science ®Google Scholar
• Pearson, K. (1901). LIII. On lines and planes of closest fit to systems of points in space. The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science, 2(11), 559–572. https://doi.org/10.1080/14786440109462720
   Google Scholar
• Perez de Isla, L., Alonso, R., Watts, G. F., Mata, N., Saltijeral Cerezo, A., Muñiz, O., Fuentes, F., Diaz-Diaz, J. L., de Andrés, R., Zambón, D., Rubio-Marin, P., Barba-Romero, M. A., Saenz, P., Sanchez Muñoz-Torrero, J. F., Martinez-Faedo, C., Miramontes-Gonzalez, J. P., Badimón, L., & Mata, P. (2016). Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-Year SAFEHEART Registry follow-up. Journal of the American College of Cardiology, 67(11), 1278–1285. https://doi.org/10.1016/j.jacc.2016.01.008
   PubMed Web of Science ®Google Scholar
• Petrilli, W. L., Adam, G. C., Erdmann, R. S., Abeywickrema, P., Agnani, V., Ai, X., Baysarowich, J., Byrne, N., Caldwell, J. P., Chang, W., DiNunzio, E., Feng, Z., Ford, R., Ha, S., Huang, Y., Hubbard, B., Johnston, J. M., Kavana, M., Lisnock, J.-M., … Imbriglio, J. E. (2020). From screening to targeted degradation: strategies for the discovery and optimization of small molecule ligands for PCSK9. Cell Chemical Biology, 27(1), 32–40e3. https://doi.org/10.1016/j.chembiol.2019.10.002
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43(W1), W443–7. https://doi.org/10.1093/nar/gkv315
   PubMed Web of Science ®Google Scholar
• Silverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016). Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis. JAMA, 316(12), 1289–1297. https://doi.org/10.1001/jama.2016.13985
   PubMed Web of Science ®Google Scholar
• Sun, H., Wang, J., Liu, S., Zhou, X., Dai, L., Chen, C., Xu, Q., Wen, X., Cheng, K., Sun, H., & Yuan, H. (2021). Discovery of novel small molecule inhibitors disrupting the PCSK9-LDLR interaction. Journal of Chemical Information and Modeling, 61(10), 5269–5279. https://doi.org/10.1021/acs.jcim.1c00521
   PubMed Web of Science ®Google Scholar
• Tabachnick, B. G., & Fidell, L. S. (2018). Using multivariate statistics. Pearson.
   Google Scholar
• Taechalertpaisarn, J., Zhao, B., Liang, X., & Burgess, K. (2018). Small molecule inhibitors of the PCSK9. LDLR interaction. Journal of the American Chemical Society, 140(9), 3242–3249. https://doi.org/10.1021/jacs.7b09360
   PubMed Web of Science ®Google Scholar
• Wadhera, R. K., Steen, D. L., Khan, I., Giugliano, R. P., & Foody, J. M. (2016). A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality. Journal of Clinical Lipidology, 10(3), 472–489. https://doi.org/10.1016/j.jacl.2015.11.010
   PubMed Web of Science ®Google Scholar
• Zainab, R., Kaleem, A., Ponczek, M. B., Abdullah, R., Iqtedar, M., & Hoessli, D. C. (2021). Finding inhibitors for PCSK9 using computational methods. PloS One, 16(8), e0255523. https://doi.org/10.1371/journal.pone.0255523
   PubMed Web of Science ®Google Scholar